FORMOSA LABORATORIES, INC.
台耀化學股份有限公司
Leave your email for change alerts (optional)
1995Founded
NT$1.2BPaid-in capital
2Plants
1Certifications
4Patents
NT$1–5BRevenue band
- Unified Business No.
- 96922622
- Industry
- Pharmaceuticals & Medicinal Chemicals (273)
- Main products
- Pharmaceuticals & medicinal chemicals (276)
- Location
- No. 36, Heping St., Luzhu Dist., Taoyuan City 338002, Taiwan (R.O.C.)
Taoyuan City (10,976) · Luzhu Dist. (1,965) - Listing
- Listed (TWSE) (1,087) 4746
- Registration status
- Approved / Active
- Organisation type
- Company Limited by Shares
- Founded
- 1995-12-29
- Paid-in capital
- NT$ 1,202,559,630
- Representative
- Cheng Cheng-yu
- Phone
- 03-3240895
- Website
- https://www.formosalab.com/tw
- Exporter
- Yes — registered with the Trade Administration
- Annual revenue band
- NT$1–5B
- Ownership
- Individually held
- North American market
- FDA drug establishment registration
- Representative tenure
- In office since 2013-07 (13 yrs); last handover 2013-07
- Growth & profitability
- Revenue 2026-09 YoY +17.2%, year-to-date -1.0%
Gross margin 41%, operating margin 10.9%, net margin -1.7% (2026-Q2 YTD) - Compliance record
- FDA import refusal: 1 product(s), latest 2021-07-29
Environmental penalties: 8 case(s) in 5 years, latest 2026-03-23, fines NT$ 925,000 (industrial waste; toxic chemicals; water pollution)
Labour Standards Act penalties: 3 case(s) in 5 years, latest 2025-07-04, fines NT$ 170,000 (Art. 32; Art. 22) — matched by company name
Occupational safety penalties: 2 case(s) in 5 years, latest 2025-09-25, fines NT$ 200,000 (Art. 184; Art. 178) — matched by company name
Plants 2
- Luzhu Plant 2 · No. 36, 36-1, Heping St., Luzhu Dist., Taoyuan City In production
- Luzhu Plant · No. 36, 36-1, Heping St. / No. 398, Sec. 2, Youguan Rd., Luzhu Dist., Taoyuan City In production
Certifications 1
- GMP (261)Self-reported
Patents 4
- 2025 Compound for conjugation, conjugate and pharmaceutical composition comprising the same
- 2022 Method for preparing ferric carboxymaltose
- 2022 Crystalline form of baricitinib and preparation method thereof
North American market evidence 2
- FDA drug establishment registration 3003420376 12/31/2026
ANALYSIS; API MANUFACTURE; LABEL and more (5) - FDA import refusal 3003420376 2021-07-29
ULTRAVIOLET SCREEN/SUNSCREEN N.E.C.
Recent changes 1
- PenaltiesEnvironmental penalties: latest case 2026-03-23; 8 case(s) in 5 years, fines NT$ 925,000
RSS feed · Recent changes at Taiwanese manufacturers →
Similar companies 10
- PUXIN GAS CO., LTD. · Tainan City < NT$20M estimated
Shared: Other chemical materials & products wholesale n.e.c. - Nung Yeh Pu Shou Yi Yen Chiu Suo · New Taipei City NT$100–500M estimated
Shared: Pharmaceuticals & medicinal chemicals - Chien Shen Kuo Yao Factory · Tainan City NT$100–500M estimated
Shared: Pharmaceuticals & medicinal chemicals - YI-JIN PROMOLD ENTERPRISE LTD. · Yunlin County NT$20–100M estimated
Shared: Pharmaceuticals & medicinal chemicals - TFBS BIOSCIENCE, INC. · New Taipei City Emerging stock (TPEx) NT$100–500M
Shared: GMP - SAN YUEH CHEMICAL CORPORATION · Chiayi County < NT$20M estimated
Shared: Other chemical materials & products wholesale n.e.c. - INTECH BIOPHARM LTD. · Hsinchu County Listed (TPEx) NT$20–100M
Shared: GMP - Reliance Biosciences Incorporated · New Taipei City NT$20–100M estimated
Shared: Other chemical materials & products wholesale n.e.c. - FULLHOPE BIOMEDICAL CO., LTD. · New Taipei City Emerging stock (TPEx) NT$20–100M
Shared: GMP - HeXun Biosciences Co., Ltd. · Taoyuan City Listed (TPEx) NT$100–500M
Shared: GMP